Page last updated: 2024-10-27

gabapentin and Cardiomyopathies

gabapentin has been researched along with Cardiomyopathies in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tellor, KB1
Ngo-Lam, R1
Badran, D1
Armbruster, AL1
Schwarze, MW1

Other Studies

1 other study available for gabapentin and Cardiomyopathies

ArticleYear
A rare case of a gabapentin-induced cardiomyopathy.
    Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:4

    Topics: Adult; Cardiomyopathies; Female; Gabapentin; gamma-Aminobutyric Acid; Humans

2019